We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+17.25%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$354M
AUM Growth
+$43.2M
Cap. Flow
+$30.3M
Cap. Flow %
8.54%
Top 10 Hldgs %
31.72%
Holding
1,674
New
354
Increased
213
Reduced
237
Closed
746

Top Buys

Rank Stock Value
1
CDTX
Cidara Therapeutics
CDTX
+$23.5M
2
BMO icon
Bank of Montreal
BMO
+$13.2M
3
MPWR icon
Monolithic Power Systems
MPWR
+$10.1M
4
SILJ icon
Amplify Junior Silver Miners ETF
SILJ
+$9.5M
5
COPX icon
Global X Copper Miners ETF NEW
COPX
+$8.61M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.8M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$4.39M
3
MSFT icon
Microsoft
MSFT
+$3.76M
4
SGML icon
Sigma Lithium
SGML
+$3.53M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Financials 17.75%
3 Technology 15.74%
4 Industrials 7.52%
5 Consumer Discretionary 5.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PFE icon
1326
PUT
Pfizer
PFE
$150B
– –
-457
Closed -$11K
PFGC icon
1327
Performance Food Group
PFGC
$16.9B
– –
-14
Closed -$1K
PGEN icon
1328
Precigen
PGEN
$2.45B
– –
-682
Closed -$2K
PGRE
1329
DELISTED
Paramount Group
PGRE
– –
-10,000
Closed -$65K
PHR icon
1330
Phreesia
PHR
$758M
– –
-7,800
Closed -$183K
PLAY icon
1331
Dave & Buster's
PLAY
$361M
– –
-1,365
Closed -$24K
PLCE icon
1332
Children's Place
PLCE
$55.1M
– –
-6,024
Closed -$37K
PLRX icon
1333
Pliant Therapeutics
PLRX
$66.3M
– –
-25,400
Closed -$37K
PLSE icon
1334
Pulse Biosciences
PLSE
$3.09B
– –
-86
Closed -$1K
PLTR icon
1335
CALL
Palantir
PLTR
$411B
– –
-6
Closed -$1K
PLTR icon
1336
Palantir
PLTR
$411B
– –
-3,679
Closed -$671K
PLTR icon
1337
PUT
Palantir
PLTR
$411B
– –
-190
Closed -$34K
PLUG icon
1338
Plug Power
PLUG
$3.2B
$0 ﹤0.01%
300
-773
-72% -$2.02K
PLYM
1339
DELISTED
Plymouth Industrial REIT
PLYM
– –
-25,000
Closed -$558K
PMVP icon
1340
PMV Pharmaceuticals
PMVP
$67.2M
– –
-15,000
Closed -$21K
POET icon
1341
CALL
POET Technologies
POET
$1.53B
– –
-804
Closed -$4K
POET icon
1342
POET Technologies
POET
$1.53B
– –
-14,977
Closed -$82K
POOL icon
1343
Pool Corp
POOL
$7.25B
– –
-410
Closed -$127K
PPLT
1344
CALL
abrdn Physical Platinum Shares ETF
PPLT
$2.05B
– –
-80
Closed -$1K
PPTA
1345
Perpetua Resources
PPTA
$3.16B
– –
-3,000
Closed -$60K
PRE icon
1346
Prenetics Global
PRE
$318M
– –
-1,053
Closed -$14K
PROP icon
1347
Prairie Operating Co
PROP
$85.8M
– –
-9,800
Closed -$19K
PSN icon
1348
Parsons
PSN
$5.16B
– –
-68
Closed -$5K
PSX icon
1349
Phillips 66
PSX
$90B
$0 ﹤0.01%
+5
New +$673
PTON icon
1350
CALL
Peloton Interactive
PTON
$2.38B
– –
-132
Closed -$1K
52 53
54
55 56

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return

FNY Investment Advisers's Q4 2025 Portfolio in Review

As of Q4 2025, FNY Investment Advisers held 1,674 positions worth $354M, up 14% from $311M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

FNY Investment Advisers deployed $30.3M of net new capital in Q4 2025, opening 354 new positions and adding to 213 existing holdings. Its largest new stake was Cidara Therapeutics: 145,533 shares worth $32.1M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 12% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Sibanye-Stillwater, an estimated $4.39M trimmed.

  • FNY Investment Advisers's largest Q4 2025 buy was Cidara Therapeutics: 145,533 shares worth $32.1M.
  • FNY Investment Advisers added most to Morgan Stanley in Q4 2025, an estimated $6.17M increase.
  • FNY Investment Advisers's biggest Q4 2025 reduction was Sibanye-Stillwater, cutting an estimated $4.39M.
  • FNY Investment Advisers fully exited Verona Pharma in Q4 2025, selling an estimated $15.8M.
  • FNY Investment Advisers's ten largest holdings make up 32% of its $354M portfolio in Q4 2025.
  • FNY Investment Advisers opened 354 new positions and closed 746 in Q4 2025.
  • FNY Investment Advisers's portfolio value rose 14% quarter-over-quarter to $354M.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.